VIN2

1 clinical trials · Condition

Record	Firm	Date
Evaluation of VGX-3100 and Electroporation Alone or in Combination With Imiquimod for the Treatment of HPV-16 and/or HPV-18 Related Vulvar HSIL (Also Referred as: VIN 2 or VIN 3) (NCT03180684)	Inovio Pharmaceuticals	2017-08-31

Every clearance here is in the API, with alerts when new ones post.